<div id="readability-page-1"><div>RNS Number : 6459P Chesnara PLC 03 July 2025 Not for release, publication or distribution, IN WHOLE OR IN PART, directly or indirectly, in or into THE UNITED STATES, AUSTRALIA, CANADA, Japan, the republic of south africa OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.THIS ANNOUNCEMENT IS AN ADVERTISEMENT FOR THE PURPOSES OF THE UK PROSPECTUS REGULATION RULES OF THE FINANCIAL CONDUCT AUTHORITY (THE &#34;FCA&#34;) AND DOES NOT CONSTITUTE A PROSPECTUS OR A PROSPECTUS EQUIVALENT DOCUMENT. NEITHER THIS ANNOUNCEMENT NOR ANY PART OF IT SHOULD FORM THE BASIS OF OR BE RELIED ON IN CONNECTION WITH OR ACT AS AN INDUCEMENT TO ENTER INTO ANY CONTRACT OR COMMITMENT WHATSOEVER. NOTHING IN THIS ANNOUNCEMENT SHOULD BE INTERPRETED AS A TERM OR CONDITION OF THE RIGHTS ISSUE. ANY DECISION TO PURCHASE, SUBSCRIBE FOR, OTHERWISE ACQUIRE, SELL OR OTHERWISE DISPOSE OF ANY NIL PAID RIGHTS, FULLY PAID RIGHTS OR NEW SHARES MUST BE MADE ONLY ON THE BASIS OF THE INFORMATION CONTAINED IN THE PROSPECTUS ONCE PUBLISHED. COPIES OF THE PROSPECTUS WILL, FOLLOWING PUBLICATION, BE AVAILABLE FROM THE REGISTERED OFFICE OF THE COMPANY AND ON ITS WEBSITE AT WWW.CHESNARA.CO.UK/INVESTORS.Chesnara PLC3 July 2025PUBLICATION OF PROSPECTUSFurther to the announcement relating to the rights issue to raise total gross proceeds of approximately £140 million (the &#34;Rights Issue&#34;) released earlier today by Chesnara plc (&#34;Chesnara&#34; or the &#34;Company&#34; and, together with its subsidiaries, the &#34;Group&#34;), the Company is pleased to announce that the FCA has approved the prospectus dated 3 July 2025 (the &#34;Prospectus&#34;) in connection with the Rights Issue and the Prospectus has been published by the Company.The Prospectus contains further details of the Rights Issue and will be posted to shareholders of the Company that have elected to receive hard copies of such shareholder documentation on 4 July 2025. The Prospectus is also available on the Company's website, www.chesnara.co.uk/investors.A copy of the Prospectus will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.EnquiriesInvestors:ChesnaraSteve Murray, Group Chief Executive OfficerTom Howard, Group Chief Financial OfficerSam Perowne, Head of Strategic Development &amp; Investor Relations sam.perowne@chesnara.co.ukFenchurch Advisory Partners (Lead Financial Advisor to Chesnara)Paul MillerYiannis KourrisDavid Cochrane+44 (0) 20 7382 2222RBC Capital Markets (Sponsor, Global Coordinator, Lead Underwriter, Joint Financial Advisor and Corporate Broker to Chesnara) James AgnewEzzedine Ben FrejJamil Miah+44 (0) 20 7653 4000ABN AMRO (Joint Bookrunner and Underwriter to Chesnara)Julie WakkieMaarten Altena+ 31 (0) 20 628 48 66Panmure Liberum (Joint Bookrunner and Joint Corporate Broker to Chesnara)Stephen JonesDavid WatkinsAtholl Tweedie+ 44 (0) 20 3100 2000Media:Teneo Oscar Burnettchesnara@teneo.com+44 (0) 20 7427 5435The person responsible for arranging for the release of this announcement on behalf of Chesnara is Al Lonie, Company Secretary.IMPORTANT NOTICESThis announcement has been issued by and is the sole responsibility of the Company. The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may or should be placed by any person for any purpose whatsoever on the information contained in this announcement or on its accuracy, fairness or completeness. The information in this announcement is subject to change without notice.This announcement is an advertisement for the purposes of the Prospectus Regulation Rules of the FCA and does not constitute a prospectus (or prospectus equivalent document) and investors should not subscribe for, purchase, otherwise acquire, sell or otherwise dispose of any securities referred to in this announcement except on the basis of information in the Prospectus. Neither this announcement nor any part of it should form the basis of or be relied on in connection with or act as an inducement to enter into any contract or commitment whatsoever. Nothing in this announcement should be interpreted as a term or condition of the Rights Issue.A copy of the Prospectus is available on the Company's website at www.chesnara.co.uk/investors. Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this announcement. The Prospectus provides further details of the securities being offered pursuant to the Rights Issue. This announcement is for information purposes only and is not intended to constitute, and should not be construed as, an offer to sell or issue, or a solicitation of any offer to purchase, subscribe for or otherwise acquire, the Nil Paid Rights, the Fully Paid Rights and the New Ordinary Shares of the Company in Australia, Canada, Japan, South Africa or in any other jurisdiction where such offer or sale would be unlawful and, subject to certain exceptions, should not be distributed, forwarded to or transmitted in or into any jurisdiction, where to do so might constitute a violation of local securities laws or regulations. The distribution of this announcement, the Prospectus (once published), and any other document relating to the offering or transfer of Nil Paid Rights, Fully Paid Rights or New Ordinary Shares into jurisdictions other than the United Kingdom may be restricted by law, and, therefore, persons into whose possession this announcement, the Prospectus (once published), and/or any accompanying documents comes should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws of such jurisdiction. In particular, subject to certain exceptions, this announcement, the Prospectus (once published) and the provisional allotment letters (once printed) should not be distributed, forwarded to or transmitted in or into Australia, Canada, Japan, South Africa, or any other jurisdiction where the extension or availability of the Rights Issue (and any other transaction contemplated thereby) would breach any applicable law or regulation.This announcement does not constitute a recommendation concerning any investor's options with respect to the Rights Issue. The price and value of securities can go down as well as up. Past performance is not a guide to future performance. The contents of this announcement are not to be construed as legal, business, financial or tax advice. Each shareholder or prospective investor should consult his, her or its own legal adviser, business adviser, financial adviser or tax adviser for legal, financial, business or tax advice.RBC Europe Limited (&#34;RBC&#34;) is authorised by the Prudential Regulation Authority (the &#34;PRA&#34;) and regulated in the United Kingdom by the Financial Conduct Authority (the &#34;FCA&#34;) and the PRA. ABN AMRO Bank N.V. (&#34;ABN AMRO&#34;) is regulated by the European Central Bank in close cooperation with the Dutch Central Bank (De Nederlandsche Bank) and the Dutch Authority for the Financial Markets (Autoriteit Financiële Markten) in the Netherlands. Panmure Liberum Limited (&#34;Panmure Liberum&#34;) is authorised and regulated in the United Kingdom by the FCA. Each of RBC, ABN AMRO and Panmure Liberum is acting exclusively for the Company and no one else in connection with the Rights Issue, and will not regard any other person (whether or not a recipient of this announcement) as a client in connection with the Rights Issue and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for providing advice to any person in relation to the Rights Issue or any other matter, transaction or arrangement referred to in this announcement.None of RBC, ABN AMRO or Panmure Liberum, nor any of their respective subsidiaries, branches or affiliates, nor any of their respective directors, officers, employees or advisers accepts any responsibility or liability whatsoever for the contents of this announcement, or makes any representation or warranty, express or implied, as to its accuracy, completeness or verification or for any other statement made or purported to be made by it, or on its behalf, in connection with the Company, the Nil Paid Rights, the Fully Paid Rights, the Provisional Allotment Letter, the New Ordinary Shares or the Rights Issue. Subject to applicable law, each of RBC, ABN AMRO and Panmure Liberum disclaims all and any liability or responsibility whatsoever (whether direct or indirect, whether in tort, contract or otherwise) which it might otherwise have in respect of the Rights Issue, this announcement or any statement contained herein, or otherwise.This announcement is not for publication or distribution in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.INFORMATION TO DISTRIBUTORSSolely for the purposes of the product governance requirements of Chapter 3 of the FCA Handbook Product Intervention and Product Governance Sourcebook (the &#34;UK Product Governance Requirements&#34;), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any &#34;manufacturer&#34; (for the purposes of the UK Product Governance Requirements) may otherwise have with respect thereto, the New Ordinary Shares have been subject to a product approval process, which has determined that the New Ordinary Shares are: (a) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in Chapter 3 of the FCA Handbook Conduct of Business Sourcebook; and (b) eligible for distribution through all permitted distribution channels (the &#34;Target Market Assessment&#34;).Notwithstanding the Target Market Assessment, &#34;distributors&#34; (for the purposes of the UK Product Governance Requirements) should note that: the price of the New Ordinary Shares may decline and investors could lose all or part of their investment; the New Ordinary Shares offer no guaranteed income and no capital protection; and an investment in the New Ordinary Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to any contractual, legal or regulatory selling restrictions in relation to the offer of New Ordinary Shares. Furthermore, it is noted that, notwithstanding the Target Market Assessment, the Joint Bookrunners will only procure investors who meet the criteria of professional clients and eligible counterparties.For the avoidance of doubt, the Target Market Assessment does not constitute: (i) an assessment of suitability or appropriateness for the purposes of Chapters 9A or 10A, respectively, of the FCA Handbook Conduct of Business Sourcebook; or (ii) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to, the New Ordinary Shares. Each distributor is responsible for undertaking its own target market assessment in respect of the New Ordinary Shares and determining appropriate distribution channels.This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END PDIEAFXDEENSEFA</div></div>

Chesnara PLC has published a prospectus approved by the FCA in connection with its rights issue aimed at raising approximately £140 million. The prospectus will be sent to shareholders who opted for hard copies on July 4, 2025, and will also be available on the company's website. This announcement serves as an advertisement under the UK Prospectus Regulation Rules and does not constitute a prospectus or an inducement to enter into any contract. Investors are advised to rely solely on the information contained in the prospectus for any decisions regarding the rights issue.

REG - Chesnara PLC - Publication of a Prospectus